{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:17:54Z","timestamp":1792520274750,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573381"],"award-info":[{"award-number":["81573381"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2017-I2M-1-012"],"award-info":[{"award-number":["2017-I2M-1-012"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-I2M-1-070"],"award-info":[{"award-number":["2021-I2M-1-070"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jconrel.2026.115047","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T15:41:09Z","timestamp":1779550869000},"page":"115047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Antimicrobial peptide-derived lipid nanoparticles enable lung-targeted mRNA therapy for multidrug-resistant bacterial pneumonia"],"prefix":"10.1016","volume":"396","author":[{"given":"Xucheng","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansha","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengya","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jconrel.2026.115047_bb0005","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115047_bb0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/CPM.0000000000000108","article-title":"Understanding persistent bacterial lung infections: clinical implications informed by the biology of the microbiota and biofilms","volume":"23","author":"Pragman","year":"2016","journal-title":"Clin. Pulm. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115047_bb0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrmicro.2017.122","article-title":"New opportunities for managing acute and chronic lung infections","volume":"16","author":"Cookson","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115047_bb0020","doi-asserted-by":"crossref","DOI":"10.1007\/s00284-022-03061-7","article-title":"Current treatment strategies against multidrug-resistant bacteria: a review","volume":"79","author":"Parmanik","year":"2022","journal-title":"Curr. Microbiol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115047_bb0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.pop.2018.04.001","article-title":"Guidelines for the evaluation and treatment of pneumonia","volume":"45","author":"Grief","year":"2018","journal-title":"Prim. Care"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115047_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/s40780-024-00367-5","article-title":"Antibiotic therapy for bacterial pneumonia","volume":"10","author":"Kato","year":"2024","journal-title":"J. Pharm. Health Care Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115047_bb0035","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1016\/j.cub.2015.11.017","article-title":"Antimicrobial peptides","volume":"26","author":"Zhang","year":"2016","journal-title":"Curr. Biol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115047_bb0040","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrmicro1098","article-title":"Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?","volume":"3","author":"Brogden","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115047_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.616979","article-title":"Lessons learned from clinical trials using antimicrobial peptides (AMPs)","volume":"12","author":"Dijksteel","year":"2021","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115047_bb0050","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1152\/physrev.00039.2023","article-title":"Lung antimicrobial proteins and peptides: from host defense to therapeutic strategies","volume":"104","author":"Di","year":"2024","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115047_bb0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115047_bb0060","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1080\/07388551.2020.1796576","article-title":"Antimicrobial peptides as therapeutic agents: opportunities and challenges","volume":"40","author":"Mahlapuu","year":"2020","journal-title":"Crit. Rev. Biotechnol."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115047_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11101338","article-title":"Engineering approaches for the development of antimicrobial peptide-based antibiotics","volume":"11","author":"Kang","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.jconrel.2026.115047_bb0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-bioeng-010220-095711","article-title":"Engineering selectively targeting antimicrobial peptides","volume":"23","author":"Lei","year":"2021","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115047_bb0075","doi-asserted-by":"crossref","first-page":"113818","DOI":"10.1016\/j.addr.2021.05.028","article-title":"Antimicrobial peptides towards clinical application: delivery and formulation","volume":"175","author":"Wang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115047_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-025-02928-x","article-title":"Antimicrobial peptide delivery to lung as peptibody mRNA in anti-inflammatory lipids treats multidrug-resistant bacterial pneumonia","author":"Xue","year":"2025","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115047_bb0085","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat Rev Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115047_bb0090","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.1038\/s41467-021-27493-0","article-title":"An ionizable lipid toolbox for RNA delivery","volume":"12","author":"Han","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115047_bb0095","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/s41591-022-02061-1","article-title":"The landscape of mRNA nanomedicine","volume":"28","author":"Huang","year":"2022","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115047_bb0100","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41565-023-01563-4","article-title":"Strategies for non-viral vectors targeting organs beyond the liver","volume":"19","author":"Kim","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115047_bb0105","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1039\/D5BM00322A","article-title":"Non-viral mRNA delivery to the lungs","volume":"13","author":"Healy","year":"2025","journal-title":"Biomater. Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115047_bb0110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrmicro2128","article-title":"Antimicrobial mechanisms of phagocytes and bacterial evasion strategies","volume":"7","author":"Flannagan","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115047_bb0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrm1104","article-title":"Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens","volume":"4","author":"Rosenberger","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115047_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11071971","article-title":"Cell-penetrating peptide-based delivery of macromolecular drugs: development, strategies, and progress","volume":"11","author":"Sun","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115047_bb0125","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/nn4057269","article-title":"Cell-penetrating peptides: design, synthesis, and applications","volume":"8","author":"Copolovici","year":"2014","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115047_bb0130","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.addr.2012.11.007","article-title":"Curb challenges of the \u201cTrojan Horse\u201d approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery","volume":"65","author":"Huang","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"33","key":"10.1016\/j.jconrel.2026.115047_bb0135","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw0730","article-title":"Lipid nanoparticles for mRNA delivery in brain via systemic administration","volume":"11","author":"Cao","year":"2025","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115047_bb0140","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbamem.2012.10.010","article-title":"Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure","volume":"1828","author":"Bahnsen","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115047_bb0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1472-765X.2011.03168.x","article-title":"Cell-penetrating peptides as antifungals towards Malassezia sympodialis","volume":"54","author":"Holm","year":"2012","journal-title":"Lett. Appl. Microbiol."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115047_bb0150","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.bbamem.2006.03.030","article-title":"LL-37, the only human member of the cathelicidin family of antimicrobial peptides","volume":"1758","author":"D\u00fcrr","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115047_bb0155","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat. Med."},{"issue":"41","key":"10.1016\/j.jconrel.2026.115047_bb0160","doi-asserted-by":"crossref","first-page":"34101","DOI":"10.1074\/jbc.M112.394452","article-title":"Cathepsin G-regulated release of formyl peptide receptor agonists modulate neutrophil effector functions","volume":"287","author":"Woloszynek","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.jconrel.2026.115047_bb0165","doi-asserted-by":"crossref","first-page":"15694","DOI":"10.1021\/acsomega.9b02278","article-title":"Conjugation of cell-penetrating peptides to antimicrobial peptides enhances antibacterial activity","volume":"4","author":"Lee","year":"2019","journal-title":"ACS Omega"},{"issue":"46","key":"10.1016\/j.jconrel.2026.115047_bb0170","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1002\/adma.201302952","article-title":"Synergistic co-delivery of membrane-disrupting polymers with commercial antibiotics against highly opportunistic bacteria","volume":"25","author":"Ng","year":"2013","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115047_bb0175","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ja.2014.4","article-title":"Antimicrobial properties and interaction of two Trp-substituted cationic antimicrobial peptides with a lipid bilayer","volume":"67","author":"Bi","year":"2014","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"21","key":"10.1016\/j.jconrel.2026.115047_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24213888","article-title":"Photon-induced superior antibacterial activity of palladium-decorated, magnetically separable Fe3O4\/Pd\/mpg-C3N4 nanocomposites","volume":"24","author":"Thakur","year":"2019","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115047_bb0185","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41579-018-0019-y","article-title":"Implant infections: adhesion, biofilm formation and immune evasion","volume":"16","author":"Arciola","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115047_bb0190","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cell.2012.02.055","article-title":"A self-produced trigger for biofilm disassembly that targets exopolysaccharide","volume":"149","author":"Kolodkin-Gal","year":"2012","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115047_bb0195","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1128\/jb.171.6.3211-3217.1989","article-title":"Outer membrane protein H1 of Pseudomonas aeruginosa: purification of the protein and cloning and nucleotide sequence of the gene","volume":"171","author":"Bell","year":"1989","journal-title":"J. Bacteriol."},{"issue":"25","key":"10.1016\/j.jconrel.2026.115047_bb0200","doi-asserted-by":"crossref","first-page":"25939","DOI":"10.1074\/jbc.C400164200","article-title":"Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa","volume":"279","author":"Akama","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115047_bb0205","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1128\/IAI.72.12.6757-6763.2004","article-title":"ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies","volume":"72","author":"Garmory","year":"2004","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115047_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071781","article-title":"Two component regulatory systems and antibiotic resistance in Gram-Negative pathogens","volume":"20","author":"Bhagirath","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6701","key":"10.1016\/j.jconrel.2026.115047_bb0215","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1126\/science.adk9428","article-title":"In vivo editing of lung stem cells for durable gene correction in mice","volume":"384","author":"Sun","year":"2024","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115047_bb0220","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115047_bb0225","first-page":"86","article-title":"Engineering LNPs with polysarcosine lipids for mRNA delivery","volume":"37","author":"Kang","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115047_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113907","article-title":"Functional lipid nanoparticles for safe delivery of macromolecular antibiotics to gram-negative bacteria","volume":"384","author":"Ang","year":"2025","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115047_bb0235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41565-019-0600-1","article-title":"Vitamin lipid nanoparticles enable adoptive macrophage transfer for the treatment of multidrug-resistant bacterial sepsis","volume":"15","author":"Hou","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.115047_bb0240","article-title":"Long term chronic Pseudomonas aeruginosa airway infection in mice","volume":"85","author":"Facchini","year":"2014","journal-title":"J. Vis. Exp."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115047_bb0245","doi-asserted-by":"crossref","DOI":"10.1007\/s11908-016-0516-y","article-title":"Relevant cytokines in the management of community-acquired pneumonia","volume":"18","author":"Rendon","year":"2016","journal-title":"Curr. Infect. Dis. Rep."},{"issue":"52","key":"10.1016\/j.jconrel.2026.115047_bb0250","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115047_bb0255","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat Rev Mater."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115047_bb0260","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/mt.2013.258","article-title":"Skin electroporation of a plasmid encoding hCAP-18\/LL-37 host defense peptide promotes wound healing","volume":"22","author":"Steinstraesser","year":"2014","journal-title":"Mol. Ther."},{"issue":"40","key":"10.1016\/j.jconrel.2026.115047_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202004452","article-title":"Leveraging mRNA sequences and nanoparticles to deliver SARS-CoV-2 antigens in vivo","volume":"32","author":"Zeng","year":"2020","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115047_bb0270","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","article-title":"Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospects","volume":"20","author":"Kon","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115047_bb0275","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/s41551-025-01511-8","article-title":"Targeting and tracking mRNA lipid nanoparticles at the particle, transcript and protein level","volume":"9","author":"Kang","year":"2025","journal-title":"Nat Biomed Eng."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115047_bb0280","article-title":"A new anti-immune evasion strategy against methicillin-resistant Staphylococcus aureus (MRSA) infections: simulating complement immunotherapy based on complement-mimic antibiotic delivery system","volume":"4","author":"Hou","year":"2021","journal-title":"Adv. Ther."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115047_bb0285","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s11095-015-1825-9","article-title":"Multi-functional liposomes enhancing target and antibacterial immunity for antimicrobial and anti-biofilm against methicillin-resistant Staphylococcus aureus","volume":"33","author":"Meng","year":"2016","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115047_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260627","article-title":"Mouse pneumonia model by Acinetobacter baumannii multidrug resistant strains: comparison between intranasal inoculation, intratracheal instillation and oropharyngeal aspiration techniques","volume":"16","author":"Bergamini","year":"2021","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115047_bb0295","first-page":"L451","article-title":"Role of the Fas\/FasL system in a model of RSV infection in mechanically ventilated mice","volume":"301","author":"van den Berg","year":"2011","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:53:16Z","timestamp":1787579596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926004505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":59,"alternative-id":["S0168365926004505"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115047","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial peptide-derived lipid nanoparticles enable lung-targeted mRNA therapy for multidrug-resistant bacterial pneumonia","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115047"}}